HCW Biologics Inc. (HCWB) vs Moolec Science SA (MLEC)

HCW Biologics Inc. and Moolec Science SA are both Biotechnology companies. HCW Biologics Inc. and Moolec Science SA are of similar size ($4.3M and $4.2M). Moolec Science SA has the higher net margin (−7.18% vs −329.4%) and the higher return on invested capital (0.00% vs −36.2%). Across the 16 metrics below, Moolec Science SA leads on 13 and HCW Biologics Inc. on 3.

Valuation

Metric HCWB MLEC Biotechnology median
P/E n/m n/m 7.88
P/S 0.38 0.00 11.47
P/B 0.35 0.10 2.52
Price to free cash flow n/m 0.08 21.16
EV/EBITDA n/m 1.79 0.74
EV/Sales 1.30 0.14 10.73
Earnings yield (1,429.91%) (1,399.59%) (28.84%)
Free cash flow yield (483.74%) 1,260.08% (23.03%)

Profitability

Metric HCWB MLEC Biotechnology median
Gross margin 95.91% 39.67% 65.16%
Operating margin (114.02%) 4.09% 0.00%
Net margin (329.38%) (7.18%) 0.00%
Free cash flow margin (180.57%) 0.00% 0.00%
Return on equity (600.32%) 0.00% (57.72%)
Return on assets (79.52%) 0.00% (49.22%)
Return on invested capital (36.15%) 0.00% 0.00%

Growth

Metric HCWB MLEC Biotechnology median
Revenue growth (TTM) 706.96% — 5.64%
EPS growth (last fiscal year) 65.49% (447.53%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HCWB MLEC Biotechnology median
Debt to equity 0.88 4.37 0.00
Current ratio 0.06 0.15 4.73
Net debt to EBITDA (0.40) (2.73) 0.96

Dividend

Metric HCWB MLEC Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric HCWB MLEC Biotechnology median
Market cap 4.18m 4.25m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack